123 related articles for article (PubMed ID: 21741199)
1. Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience.
Lazaryan A; Kalmadi S; Almhanna K; Pelley R; Kim R
Eur J Surg Oncol; 2011 Sep; 37(9):791-7. PubMed ID: 21741199
[TBL] [Abstract][Full Text] [Related]
2. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
3. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; DomÃnguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
5. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
7. Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma.
Lee JH; Lee KG; Ha TK; Jun YJ; Paik SS; Park HK; Lee KS
Am Surg; 2011 Mar; 77(3):322-9. PubMed ID: 21375845
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
9. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma.
Barauskas G; Gulbinas A; Pranys D; Dambrauskas Z; Pundzius J
J Hepatobiliary Pancreat Surg; 2008; 15(4):423-8. PubMed ID: 18670845
[TBL] [Abstract][Full Text] [Related]
10. Pancreaticoduodenectomy for periampullary adenocarcinoma.
Andersen HB; Baden H; Brahe NE; Burcharth F
J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
[TBL] [Abstract][Full Text] [Related]
11. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
[TBL] [Abstract][Full Text] [Related]
12. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.
Hsu HP; Yang TM; Hsieh YH; Shan YS; Lin PW
Ann Surg Oncol; 2007 Jan; 14(1):50-60. PubMed ID: 17054003
[TBL] [Abstract][Full Text] [Related]
13. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater.
van der Gaag NA; ten Kate FJ; Lagarde SM; Busch OR; van Gulik TM; Gouma DJ
Br J Surg; 2008 Jun; 95(6):735-43. PubMed ID: 18300268
[TBL] [Abstract][Full Text] [Related]
15. Survival after resection of ampullary carcinoma: a national population-based study.
O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
[TBL] [Abstract][Full Text] [Related]
16. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of surgical treatment of Vater's ampulla neoplasms.
Bucher P; Chassot G; Durmishi Y; Ris F; Morel P
Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078
[TBL] [Abstract][Full Text] [Related]
18. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival.
de Castro SM; van Heek NT; Kuhlmann KF; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
Surgery; 2004 Nov; 136(5):994-1002. PubMed ID: 15523392
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting morbidity, mortality and survival after pancreaticoduodenectomy for carcinoma of the ampulla of Vater.
Su CH; Shyr YM; Lui WY; P'eng FK
Hepatogastroenterology; 1999; 46(27):1973-9. PubMed ID: 10430380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
